PubMed HealthSearch

PubMed · 1410690

Reentry field data and conclusions.

Abstract

A review of the reported foliar residue data has revealed a number of deficiencies in the reentry intervals currently regulated, in particular, by the EPA and some by California. Deficiencies were also identified in the available information necessary to recommend better reentry intervals. Information regarding the frequency of exposure for individual or groups of harvesters is the most fundamental deficiency. It is needed to define a more realistic chronic criterion of allowable daily cholinesterase inhibition without cumulative symptoms. The second criterion of preventing acute overexposure is more readily defined. For the purposes of this study, the criteria of 4% mean daily inhibition and 50% acute inhibition were chosen as acceptable. Based on these criteria, the available data, and by using the unified field model assessment as the basis for comparison (Table 9), EPA reentry intervals for nine insecticides in Table 4 appear inadequate (i.e., not within the range of the model recommendations); 10 are adequate; and only one appears excessive as summarized in Table 10. A similar comparison of California's reentry intervals indicates only two may be inadequate or marginal; 13 are adequate; and five may be excessive. Although these conclusions are based on a considerable amount of residue data, the data are not equally distributed among all pesticides nor has the model been confirmed in all the cropping and harvest conditions examined. However, the model has been developed under realistic field tests, most of its premises have been confirmed in a limited number of tests, and its simulated predictions appear to parallel experience in California where pesticide use and decay conditions may have been most severe but recently well scrutinized. The model's recommendations largely substantiate the regulations developed in California. However, its conclusions definitely suggest that improved levels of protection are needed in other regions. Future reentry intervals will require more comprehensive residue data. The toxicities of detectable metabolites for a few insecticides will need to be determined. More crop residue dosing coefficients are also needed for manually harvested crops. These data must be interpreted in terms of the potential both for acute poisoning from variable residues and for chronic poisoning from repeated exposure to more consistent residues. Surveys of the temporal exposure patterns of harvesters or crews of harvesters are vital to assess the cumulative effects and set the most appropriate chronic cholinesterase response limits. While we await further data, there is sufficient information now to justify longer reentry intervals to protect harvesters nationally.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

W Popendorf. 1992. Reentry field data and conclusions.. https://pubmed.ncbi.nlm.nih.gov/1410690/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Determination of picogram levels of heptylphysostigmine in human plasma using high-performance liquid chromatography with fluorescence detection.

A sensitive (50 pg/ml) method for the determination of heptylphysostigmine in human plasma is described. The procedure is based on liquid-liquid extraction of the drug from buffered plasma, and analysis of the concentrated organic extract using high-performance liquid chromatography on a silica column, under normal-phase chromatographic conditions, with fluorescence detection. Physostigmine was used as an internal standard. The assay has been fully validated in the concentration range 50-2000 pg/ml and utilized for the analysis of clinical samples from subjects dosed with heptylphysostigmine.

Cholinesterase Inhibitors

QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.

QSAR analyses have been performed on the substituted indanone and benzylpiperidine ring substructures of a set of acetylcholinesterase, AChE, inhibitors of which 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride is a potent in vitro and ex vivo inhibitor. The method of molecular decomposition-recomposition was used to define the sets of molecular substructures and corresponding in vitro inhibition databases. A QSAR involving the magnitude of the dipole moment, the highest occupied molecular orbital (HOMO) energy, and a specific pi-orbital wave function coefficient of the substituted indanone ring substructure was constructed and found to be significant. The absence of any molecular-shape or bulk term in the QSAR, coupled with some of the relatively large substituents used to construct the QSAR, suggests considerable space is available around the indanone ring during the inhibition process. A set of QSARs were constructed and evaluated for substituents on the aromatic ring of the benzylpiperidine substructure. The most significant QSAR involves a representation of molecular shape, the largest principal moment of inertia, and the HOMO of the substituted aromatic ring. It appears that upon binding the receptor "wall" is closely fit around the benzyl ring, especially near the para position. Overall, the QSAR analysis suggests inhibition potency can be better enhanced by substitution on the indanone ring, as compared to the aromatic sites of the benzylpiperidine ring. Moreover, inhibition potency can be rapidly diminished, presumably through steric interactions with the receptor surface of AChE, by substitution of moderate to large groups on the benzyl ring, particularly at the para position.

Cholinesterase Inhibitors

Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.

Conformational analyses and molecular-shape comparisons were carried out on an analogue series of indanone-benzylpiperidine inhibitors of acetylcholinesterase (AChE). It was possible to define an active conformation with respect to the flexible geometry of the benzylpiperidine moiety, as well as an active conformation of the indanone ring-piperidine ring substructure for analogues having a single spacer group between these rings. No active conformation could be postulated for analogues having two or three spacer units between the indanone and piperidine conformation could be postulated for analogues having two or three spacer units between the indanone and piperidine rings. Still, a receptor binding model can be constructed for all indanone and piperidine ring substructures. The postulated active conformation for 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride (1a), a potent AChE inhibitor, is close to the crystal structures of 1a with respect to the indanone-piperidine substructure, but differs from the crystal structures for the benzylpiperidine moiety. However, the crystal conformations and the postulated active conformation of the benzylpiperidine portion of the AChE inhibitor are estimated to be about equally stable. A trans-decalin analogue of 1a can adopt the postulated active conformation as shown by calculation and as seen in its crystal structure. The inactivity of this analogue is explained by the added steric size of the decalin unit and/or the time-average valence geometry behavior at the spiro junction to the indanone ring.

Cholinesterase Inhibitors